PharmacoEconomics

Raw citation data, Impact Factor, Immediacy Index, Published documents, Citations received, , Most cited papers , Recent citations and documents published in this series in EconPapers.

Create citation feed for this series

Raw data:
IF AIF DOC CIT D2Y C2Y SC(%) CiY II AII 1996 0.18 0 0 0 0.08 1997 0.21 0 0 0 0.08 1998 0.22 0 0 0 0.1 1999 0.28 0 0 0 0.13 2000 0.37 1 0 0 0 0.16 2001 0.37 0 1 0 0.16 2002 0.41 0 1 0 0.19 2003 0.42 0 0 0 0.2 2004 0.47 1 0 0 0 0.21 2005 0.5 2 0 1 0 0.23 2006 0.51 1 0 3 0 0.22 2007 0.4 2 0 3 0 0.18 2008 0.42 2 0 3 0 0.21 2009 0.43 59 2 4 0 0.19
IF: Impact Factor: C2Y / D2Y AIF: Average Impact Factor for series in RePEc in year y DOC: Number of documents published in year y CIT: Number of citations to the series in year y D2Y: Number of articles published in y-1 plus y-2 C2Y: Cites in y to articles published in y-1 plus y-2 SC(%): Percentage of selft citations in y to articles published in y-1 plus y-2 CiY: Cites in year y to documents published in year y IdI: Immediacy Index: CiY / Documents.   AII: Average Immediacy Index for series in RePEc in year y
Impact Factor:	Immediacy Index:
Documents published:	Citations received:

Most cited documents in this series:

(1) RePEc:wkh:phecon:v:13:y:1998:i:3:p:293-304 ().
Cited: 12 times.

(2) RePEc:wkh:phecon:v:17:y:2000:i:5:p:461-477 ().
Cited: 4 times.

(3) RePEc:wkh:phecon:v:17:y:2000:i:5:p:501-513 ().
Cited: 3 times.

(4) RePEc:wkh:phecon:v:28:y:2010:i:8:p:649-663 Impact of European Pharmaceutical Price Regulation on Generic Price Competition: A Review (2010).
Cited: 2 times.

(5) RePEc:wkh:phecon:v:22:y:2004:i:13:p:857-876 ().
Cited: 2 times.

(6) RePEc:wkh:phecon:v:23:y:2005:i:6:p:529-536 ().
Cited: 2 times.

(7) RePEc:wkh:phecon:v:21:y:2003:i:1:p:39-48 ().
Cited: 2 times.

(8) RePEc:wkh:phecon:v:23:y:2005:i:2:p:105-111 ().
Cited: 2 times.

(9) RePEc:wkh:phecon:v:20:y:2002:i:4:p:257-265 ().
Cited: 2 times.

(10) RePEc:wkh:phecon:v:13:y:1998:i:1-part-2:p:127-134 ().
Cited: 1 times.

(11) RePEc:wkh:phecon:v:22:y:2004:i:17:p:1097-1107 ().
Cited: 1 times.

(12) RePEc:wkh:phecon:v:24:y:2006:i:8:p:797-814 ().
Cited: 1 times.

(13) RePEc:wkh:phecon:v:23:y:2005:i:7:p:651-658 ().
Cited: 1 times.

(14) RePEc:wkh:phecon:v:26:y:2008:i:9:p:781-798 ().
Cited: 1 times.

(15) RePEc:wkh:phecon:v:24:y:2006:i:4:p:401-414 ().
Cited: 1 times.

(16) RePEc:wkh:phecon:v:28:y:2010:i:8:p:609-613 Time for Cooperation in Health Economics among the Modelling Community (2010).
Cited: 1 times.

(17) RePEc:wkh:phecon:v:15:y:1999:i:3:p:291-303 ().
Cited: 1 times.

(18) RePEc:wkh:phecon:v:26:y:2008:i:9:p:733-744 ().
Cited: 1 times.

(19) RePEc:wkh:phecon:v:24:y:2006:i:2:p:123-139 ().
Cited: 1 times.

(20) RePEc:wkh:phecon:v:28:y:2010:i:10:p:799-811 Using Comparative Effectiveness Research to Inform Policy and Practice in the UK NHS: Past, Present and Future (2010).
Cited: 1 times.

(21) RePEc:wkh:phecon:v:13:y:1998:i:5:p:563-569 ().
Cited: 1 times.

(22) RePEc:wkh:phecon:v:26:y:2008:i:4:p:269-280 ().
Cited: 1 times.

(23) RePEc:wkh:phecon:v:24:y:2006:i:1:p:39-41 ().
Cited: 1 times.

(24) RePEc:wkh:phecon:v:27:y:2009:i:6:p:491-505 Converting the SF-12 into the EQ-5D: An Empirical Comparison of Methodologies (2009).
Cited: 1 times.

(25) RePEc:wkh:phecon:v:23:y:2005:i:1:p:77-91 ().
Cited: 1 times.

(26) RePEc:wkh:phecon:v:25:y:2007:i:6:p:443-454 ().
Cited: 1 times.

(27) RePEc:wkh:phecon:v:24:y:2006:i:11:p:1055-1068 ().
Cited: 1 times.

(28) RePEc:wkh:phecon:v:27:y:2009:i:12:p:983-989 Weighting Must Wait: Incorporating Equity Concerns into Cost-Effectiveness Analysis May Take Longer than Expected (2009).
Cited: 1 times.

Recent citations received in: | 2009 | 2008 | 2007 | 2006

Recent citations received in: 2009

Recent citations received in: 2008

Recent citations received in: 2007

Recent citations received in: 2006

Warning!! This is still an experimental service. The results of this service should be interpreted with care, especially in research assessment exercises. The processing of documents is automatic. There still are errors and omissions in the identification of references. We are working to improve the software to increase the accuracy of the results.

Source data used to compute the impact factor of RePEc series.